The REPROCELL Blog

Blog posts tagged:

Pharmacology-AI

Powered by an explainable machine learning platform, developed in collaboration with IBM and STFC, REPROCELL’s Pharmacology-AI is an automated system which rapidly identifies the features driving variation in patient outcomes — streamlining the development of effective patient stratification strategies. Provided and maintained by our Preclinical & Drug Discovery CRO.

Pharma AI is Changing Clinical Trials by Optimizing Patient Selection

Pharma AI is Changing Clinical Trials by Optimizing Patient Selection

27 November 2024

AI is revolutionizing clinical trials by optimizing patient selection, improving trial outcomes, and accelerating the development of new drugs.

AI in Drug Discovery: The Role of SHAP in Pharmacology

AI in Drug Discovery: The Role of SHAP in Pharmacology

11 July 2024

Learn how Explainable AI, like SHAP, is transforming drug discovery by providing transparency and clarity in machine learning models.

Subjects we write about

  1. 3D Cell Culture
  2. Cell Culture
  3. Central Lab Services
  4. Clinical Capabilities
  5. Disease Modeling
  6. Drug Discovery
  7. Gene Editing
  8. Genomic Services
  9. GMP
  10. Human Tissue Samples
  11. Human Tissue Testing
  12. IBD
  13. Life Sciences
  14. Master Cell Banks
  15. Neurons
  16. Oligonucleotide Synthesis
  17. Pharmacology-AI
  18. Precision Medicine
  19. Product Catalog
  20. Regenerative Medicine
  21. Respiratory Disease
  22. Safety Pharmacology
  23. Skin Disease
  24. Stem Cells

Stem cell and drug discovery scientists around the world use our services and products in their preclinical and clinical research.

 About REPROCELL